Skip to content

Corcept Therapeutics

US · CORT #1285 by market cap Listed 1970
63.62 -1.36 -2.09%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
2 1
■ Upgrades■ Downgrades
  • 2 upgrades vs 1 downgrade among tracked analyst rating changes.
  • Most recent: Wolfe Research moved from Hold to Sell on 2026-07-26.

Analyst consensus 4 analysts

Buy
Avg price target 165.75 +160.5%
Price target rangecurrent 63.62
Low161.00
Avg165.75
High173.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-05 CCORF -- Buy 161.00
2026-11-05 H.C. Wainwright -- Buy 165.00
2026-11-04 Piper Sandler -- Buy 173.00
2026-11-04 H.C. Wainwright -- Buy 165.00
2026-11-02 H.C. Wainwright -- Buy 165.00
2026-10-27 CCORF -- Buy 161.00
2026-10-27 Piper Sandler -- Buy 165.00
2026-10-26 CCORF -- Buy 161.00
2026-10-26 Piper Sandler -- Buy 165.00
2026-10-19 Piper Sandler -- Buy 165.00
2026-10-14 CCORF -- Buy 161.00
2026-10-07 Piper Sandler -- Buy 165.00
2026-10-01 H.C. Wainwright -- Buy 165.00
2026-09-18 H.C. Wainwright -- Buy 165.00
2026-08-21 Piper Sandler -- Buy 165.00
2026-08-18 Truist Financial -- Buy 164.00
2026-08-13 CCORF -- Buy 161.00
2026-07-30 CCORF -- Buy 161.00
2026-07-30 Piper Sandler -- Buy 165.00
2026-07-30 H.C. Wainwright -- Buy 165.00
2026-07-29 CCORF -- Buy 161.00
2026-07-29 Wolfe Research -- Sell 50.00
2026-07-26 Wolfe Research -- Sell 50.00
2026-07-09 CCORF -- Buy 135.00
2026-06-02 H.C. Wainwright -- Buy 95.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-07-26 Wolfe Research Hold → Sell 50.00
2026-05-13 UBS Hold → Buy 72.00
2026-03-26 Wolfe Research Sell → Hold --

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-03 After close ±11.96% -3.31% (in line)
2026/Q2 2026-07-29 After close ±11.98% +27.29% (beat)
2026/Q1 2026-04-30 After close ±8.03% +10.53% (beat)
2025/Q4 2026-02-24 After close ±10.55% -0.71% (in line)
2025/Q3 2025-11-04 After close ±12.65% +7.81% (in line)
2025/Q2 2025-07-31 After close ±11.59% +2.72% (in line)
2025/Q1 2025-05-05 After close ±12.10% -4.33% (in line)
2024/Q4 2025-02-26 After close ±23.17% -5.55% (in line)
2024/Q3 2024-10-30 After close ±18.92% +4.44% (in line)
2024/Q2 2024-07-29 After close ±15.02% -1.12% (in line)
2024/Q1 2024-05-01 After close ±13.10% +4.94% (in line)
2023/Q4 2024-02-15 After close ±17.81% -7.15% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Corcept Therapeutics discussion 0 comments

Add a comment